Gilead Sciences, Inc. drugs

20 results
  • biktarvy - bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate tablet

    (Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate)
    Gilead Sciences, Inc.
    BIKTARVY is a complete regimen for treating HIV-1 infection in adults and pediatric patients weighing at least 14 kg. Used in treatment-naive patients, those not virologically suppressed without known resistance, or to replace a stable regimen in virologically-suppressed patients.
  • complera - emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate tablet, film coated

    (Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate)
    Gilead Sciences, Inc.
    Complera is a complete antiretroviral regimen for treating HIV-1 infection in adults and children weighing at least 35 kg. Used as initial therapy in treatment-naive patients with HIV-1 RNA ≤100,000 copies/mL, or to replace a stable regimen in virologically suppressed patients.
  • descovy - emtricitabine and tenofovir alafenamide tablet

    (Emtricitabine And Tenofovir Alafenamide)
    Gilead Sciences, Inc.
    DESCOVY treats HIV-1 infection in adults and adolescents (≥35 kg) and pediatric patients (14–35 kg) in combination with other antiretrovirals. Also indicated as pre-exposure prophylaxis (PrEP) to reduce HIV-1 risk from sexual acquisition in at-risk adults and adolescents ≥35 kg, excluding receptive vaginal sex.
  • epclusa - velpatasvir and sofosbuvir tablet, film coated

    (Velpatasvir And Sofosbuvir)
    Gilead Sciences, Inc.
    Epclusa treats chronic hepatitis C virus (HCV) genotypes 1–6 in adults and children aged 3 and older. It is used with or without cirrhosis; patients with decompensated cirrhosis take it in combination with ribavirin.
  • genvoya - elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide tablet

    (Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide)
    Gilead Sciences, Inc.
    Genvoya is a complete HIV-1 treatment regimen for adults and children weighing at least 25 kg, used in treatment-naive patients or to replace current therapy in those virologically suppressed on stable antiretrovirals for at least 6 months with no treatment failure or resistance history.
  • letairis - ambrisentan tablet, film coated

    (Ambrisentan)
    Gilead Sciences, Inc.
    Letairis treats pulmonary arterial hypertension (PAH, WHO Group 1) in adults to improve exercise ability and delay clinical worsening. Combined with tadalafil, it reduces disease progression risk and hospitalization. Studied primarily in WHO Functional Class II–III patients with idiopathic, heritable, or connective tissue disease-associated PAH.
  • odefsey - emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide tablet

    (Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Alafenamide)
    Gilead Sciences, Inc.
    Odefsey is a complete HIV-1 treatment regimen for adults and pediatric patients (≥25 kg). Used as initial therapy (HIV-1 RNA ≤100,000 copies/mL) or to replace a stable regimen in virologically-suppressed patients with no prior treatment failure.